The drug also had a favorable safety profile, indicating its potential as a game-changer for those with type 2 inflammation.

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Discover how AI is transforming the pharma ...

The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Expert Rev Resp Med. 2012;6(6):629-638. 1 Allergy Unit 'D. Kalogeromitros', Attikon University Hospital, University of Athens Medical School, Athens, Greece 2 Allergy Department, 2nd Pediatric ...

2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD: Inhalation ...